Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.51 -0.16 (-3.53%)
As of: Oct 1, 2026 · 3:31 PM EDT

Oramed Pharmaceuticals (ORMP) Non-Current Deferred Tax Liability (2025 - 2026)

Updated

Oramed Pharmaceuticals' Non-Current Deferred Tax Liability was $39.54 million in Q2 2026, up 122.8% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Deferred Tax Liability at Oramed Pharmaceuticals came in at $7.91 million.

  • Per Business Quant data, ORMP's Non-Current Deferred Tax Liability in the three quarters before Q2 2026 was $17.75 million (Q1 2026), $7.91 million (Q4 2025) and $7.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Oramed Pharmaceuticals 192.94 Mn 192.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.54 Mn
Mar 31, 2026 17.75 Mn
Dec 31, 2025 7.91 Mn
Sep 30, 2025 7.92 Mn
API Access

Oramed Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ORMP&period=max&api_key=YOUR_API_KEY